Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 1 2Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Neoplasms, Neuroepithelial 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia, T-Cell 1Burkitt Lymphoma 1

Interventions

Rituximab 2venetoclax 1tafasitamab 1pembrolizumab 1glofitamab 1fludarabine 1avelumab 1Valproic Acid 1Melphalan 1Ifosfamide 1Gemcitabine 1Etoposide 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoma, B-Cell × Melphalan × Clear all
NCT04264039 2020-02-11

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Unknown
30 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡